FDA grants accelerated approval to Biogen treatment for rare form of ALS
April 25, 2023 at 14:47 PM EDT
The FDA has deemed Biogen's torferson reasonably likely to produce a clinical benefit for patients.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|